Presynaptic neuron and postsynaptic dopamine receptor function in long term treatment of Parkinson's disease: a neuroendocrine study.
D000368:Aged; D001058:Apomorphine / Q000494:pharmacology; D001545:Benserazide / Q000494:pharmacology; D001971:Bromocriptine / Q000494:pharmacology; D002230:Carbidopa / Q000494:pharmacology; D005260:Female; D006801:Humans; D007980:Levodopa / Q000494:pharmacology; D008297:Male; D008875:Middle Aged; D009627:Nomifensine / Q000494:pharmacology; D010300:Parkinson Disease / Q000188:drug therapy*; D011388:Prolactin / Q000097:blood; D011954:Receptors, Dopamine / Q000187:drug effects*; D012642:Selegiline / Q000494:pharmacology; D014202:Tremor / Q000188:drug therapy
D011954:Receptors, Dopamine; D009627:Nomifensine; D012642:Selegiline; D001971:Bromocriptine; D007980:Levodopa; D001545:Benserazide; D011388:Prolactin; D002230:Carbidopa; D001058:Apomorphine